Annual Gross Profit
$42.51 M
+$14.47 M+51.58%
December 31, 2023
Summary
- As of February 8, 2025, PLX annual gross profit is $42.51 million, with the most recent change of +$14.47 million (+51.58%) on December 31, 2023.
- During the last 3 years, PLX annual gross profit has fallen by -$9.51 million (-18.29%).
- PLX annual gross profit is now -18.29% below its all-time high of $52.02 million, reached on December 31, 2020.
Performance
PLX Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Gross Profit
$9.58 M
+$5.57 M+138.53%
September 30, 2024
Summary
- As of February 8, 2025, PLX quarterly gross profit is $9.58 million, with the most recent change of +$5.57 million (+138.53%) on September 30, 2024.
- Over the past year, PLX quarterly gross profit has increased by +$4.13 million (+75.79%).
- PLX quarterly gross profit is now -66.87% below its all-time high of $28.93 million, reached on June 30, 2023.
Performance
PLX Quarterly Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Gross Profit
$16.38 M
+$4.13 M+33.74%
September 30, 2024
Summary
- As of February 8, 2025, PLX TTM gross profit is $16.38 million, with the most recent change of +$4.13 million (+33.74%) on September 30, 2024.
- Over the past year, PLX TTM gross profit has dropped by -$30.72 million (-65.23%).
- PLX TTM gross profit is now -69.46% below its all-time high of $53.62 million, reached on March 31, 2020.
Performance
PLX TTM Gross Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Gross Profit Formula
Gross Profit = Revenue − Cost Of Goods Sold
PLX Gross Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +51.6% | +75.8% | -65.2% |
| 3 y3 years | -18.3% | +75.8% | -65.2% |
| 5 y5 years | +70.5% | +75.8% | -65.2% |
PLX Gross Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.2% | -66.9% | +736.3% | -66.4% | +33.7% |
| 5 y | 5-year | -18.3% | +93.2% | -66.9% | +736.3% | -69.5% | +33.7% |
| alltime | all time | -18.3% | +1433.9% | -66.9% | +247.1% | -69.5% | +613.9% |
Protalix BioTherapeutics Gross Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $9.58 M(+138.5%) | $16.38 M(+33.7%) |
| Jun 2024 | - | $4.02 M(+250.6%) | $12.25 M(-67.0%) |
| Mar 2024 | - | $1.15 M(-29.7%) | $37.16 M(-12.6%) |
| Dec 2023 | $42.51 M(+51.6%) | $1.63 M(-70.1%) | $42.51 M(-9.7%) |
| Sep 2023 | - | $5.45 M(-81.2%) | $47.10 M(-3.4%) |
| Jun 2023 | - | $28.93 M(+344.8%) | $48.76 M(+99.0%) |
| Mar 2023 | - | $6.50 M(+4.5%) | $24.50 M(-12.7%) |
| Dec 2022 | $28.05 M(+27.5%) | $6.22 M(-12.5%) | $28.05 M(+3.0%) |
| Sep 2022 | - | $7.11 M(+52.4%) | $27.23 M(-4.4%) |
| Jun 2022 | - | $4.67 M(-53.6%) | $28.47 M(+11.7%) |
| Mar 2022 | - | $10.05 M(+86.1%) | $25.50 M(+15.9%) |
| Dec 2021 | $22.00 M(-57.7%) | $5.40 M(-35.3%) | $22.00 M(-34.0%) |
| Sep 2021 | - | $8.35 M(+393.0%) | $33.34 M(+1.3%) |
| Jun 2021 | - | $1.69 M(-74.2%) | $32.91 M(-18.4%) |
| Mar 2021 | - | $6.55 M(-60.8%) | $40.36 M(-22.4%) |
| Dec 2020 | $52.02 M(+18.8%) | $16.74 M(+111.3%) | $52.02 M(+3.9%) |
| Sep 2020 | - | $7.92 M(-13.3%) | $50.09 M(-5.9%) |
| Jun 2020 | - | $9.14 M(-49.8%) | $53.21 M(-0.8%) |
| Mar 2020 | - | $18.22 M(+23.0%) | $53.62 M(+22.4%) |
| Dec 2019 | $43.80 M(+75.6%) | $14.81 M(+34.1%) | $43.80 M(+18.2%) |
| Sep 2019 | - | $11.04 M(+15.6%) | $37.06 M(+1.7%) |
| Jun 2019 | - | $9.55 M(+13.8%) | $36.44 M(+23.3%) |
| Mar 2019 | - | $8.39 M(+4.0%) | $29.54 M(+18.5%) |
| Dec 2018 | $24.94 M(+326.5%) | $8.07 M(-22.5%) | $24.94 M(+27.1%) |
| Sep 2018 | - | $10.42 M(+292.4%) | $19.61 M(+84.1%) |
| Jun 2018 | - | $2.65 M(-29.9%) | $10.66 M(+20.6%) |
| Mar 2018 | - | $3.79 M(+37.8%) | $8.84 M(+51.1%) |
| Dec 2017 | $5.85 M(+630.0%) | $2.75 M(+88.4%) | $5.85 M(+81.3%) |
| Sep 2017 | - | $1.46 M(+74.9%) | $3.23 M(+47.5%) |
| Jun 2017 | - | $835.00 K(+4.2%) | $2.19 M(+51.2%) |
| Mar 2017 | - | $801.00 K(+520.9%) | $1.45 M(+80.5%) |
| Dec 2016 | $801.00 K(-78.0%) | $129.00 K(-69.4%) | $801.00 K(+19.2%) |
| Sep 2016 | - | $422.00 K(+348.9%) | $672.00 K(-50.7%) |
| Jun 2016 | - | $94.00 K(-39.7%) | $1.36 M(-42.7%) |
| Mar 2016 | - | $156.00 K(>+9900.0%) | $2.38 M(-34.5%) |
| Dec 2015 | $3.63 M | $0.00(-100.0%) | $3.63 M(+1500.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2015 | - | $1.11 M(+0.2%) | $227.00 K(-77.8%) |
| Jun 2015 | - | $1.11 M(-21.2%) | $1.02 M(+3.0%) |
| Mar 2015 | - | $1.41 M(-141.4%) | $993.00 K(-65.7%) |
| Dec 2014 | $2.89 M(>+9900.0%) | -$3.41 M(-278.5%) | $2.89 M(-1445.6%) |
| Sep 2014 | - | $1.91 M(+76.6%) | -$215.00 K(-38.9%) |
| Jun 2014 | - | $1.08 M(-67.3%) | -$352.00 K(-212.5%) |
| Mar 2014 | - | $3.31 M(-150.8%) | $313.00 K(>+9900.0%) |
| Dec 2013 | $0.00(-100.0%) | -$6.51 M(-467.7%) | $0.00(-100.0%) |
| Sep 2013 | - | $1.77 M(+1.5%) | $5.38 M(-18.9%) |
| Jun 2013 | - | $1.75 M(-41.7%) | $6.64 M(-75.3%) |
| Mar 2013 | - | $3.00 M(-365.2%) | $26.87 M(+2.2%) |
| Dec 2012 | $26.28 M(+1721.2%) | -$1.13 M(-137.4%) | $26.28 M(-5.1%) |
| Sep 2012 | - | $3.02 M(-86.2%) | $27.70 M(+9.3%) |
| Jun 2012 | - | $21.98 M(+812.7%) | $25.36 M(-1949.6%) |
| Mar 2012 | - | $2.41 M(+719.0%) | -$1.37 M(-195.0%) |
| Dec 2011 | $1.44 M(-79.0%) | $294.00 K(-56.6%) | $1.44 M(-67.4%) |
| Sep 2011 | - | $677.00 K(-114.3%) | $4.43 M(-24.6%) |
| Jun 2011 | - | -$4.75 M(-191.0%) | $5.87 M(-47.7%) |
| Mar 2011 | - | $5.22 M(+59.1%) | $11.24 M(+63.8%) |
| Dec 2010 | $6.86 M(-315.3%) | $3.28 M(+54.9%) | $6.86 M(+1650.3%) |
| Sep 2010 | - | $2.12 M(+245.7%) | $392.00 K(-122.7%) |
| Jun 2010 | - | $613.00 K(-27.6%) | -$1.73 M(-26.2%) |
| Mar 2010 | - | $847.00 K(-126.6%) | -$2.34 M(-26.6%) |
| Dec 2009 | -$3.19 M(<-9900.0%) | -$3.19 M(<-9900.0%) | -$3.19 M(<-9900.0%) |
| Sep 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2009 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2008 | $0.00(-100.0%) | - | - |
| Jun 2008 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2008 | - | $0.00(-100.0%) | $0.00(-100.0%) |
| Dec 2005 | $115.00 K(-62.9%) | - | - |
| Dec 2004 | $310.00 K(-64.4%) | - | - |
| Dec 1999 | $871.20 K(-49.6%) | $19.90 K(+42.1%) | $871.20 K(+2.3%) |
| Sep 1999 | - | $14.00 K(-95.1%) | $851.30 K(+1.7%) |
| Jun 1999 | - | $285.20 K(-48.3%) | $837.30 K(+51.7%) |
| Mar 1999 | - | $552.10 K | $552.10 K |
| Dec 1998 | $1.73 M | - | - |
FAQ
- What is Protalix BioTherapeutics annual gross profit?
- What is the all time high annual gross profit for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics annual gross profit year-on-year change?
- What is Protalix BioTherapeutics quarterly gross profit?
- What is the all time high quarterly gross profit for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics quarterly gross profit year-on-year change?
- What is Protalix BioTherapeutics TTM gross profit?
- What is the all time high TTM gross profit for Protalix BioTherapeutics?
- What is Protalix BioTherapeutics TTM gross profit year-on-year change?
What is Protalix BioTherapeutics annual gross profit?
The current annual gross profit of PLX is $42.51 M
What is the all time high annual gross profit for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high annual gross profit is $52.02 M
What is Protalix BioTherapeutics annual gross profit year-on-year change?
Over the past year, PLX annual gross profit has changed by +$14.47 M (+51.58%)
What is Protalix BioTherapeutics quarterly gross profit?
The current quarterly gross profit of PLX is $9.58 M
What is the all time high quarterly gross profit for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high quarterly gross profit is $28.93 M
What is Protalix BioTherapeutics quarterly gross profit year-on-year change?
Over the past year, PLX quarterly gross profit has changed by +$4.13 M (+75.79%)
What is Protalix BioTherapeutics TTM gross profit?
The current TTM gross profit of PLX is $16.38 M
What is the all time high TTM gross profit for Protalix BioTherapeutics?
Protalix BioTherapeutics all-time high TTM gross profit is $53.62 M
What is Protalix BioTherapeutics TTM gross profit year-on-year change?
Over the past year, PLX TTM gross profit has changed by -$30.72 M (-65.23%)